Related Experiment Video
Updated: Jul 10, 2026
14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Influence of concomitant mitral valve dysfunction on survival after aortic valve replacement
L Torracca1, A Verzini, M De Bonis
1Department of Cardiac Surgery, San Raffaele University Hospital, Milan, Italy. torracca.lucis@hsr.it
The Journal of Cardiovascular Surgery
|October 20, 2007
Summary
Mitral regurgitation (MR) is common in severe aortic valve disease. This review examines MR
Area of Science:
- Cardiovascular Medicine
- Cardiac Surgery
Background:
- Aortic valve pathology is a leading cause of acquired valvular heart disease in Western adults.
- Mitral regurgitation (MR) frequently coexists with degenerative aortic stenosis or insufficiency, affecting 65-75% of patients undergoing aortic valve replacement.
- Severe aortic valve disease can lead to functional mitral regurgitation (FMR) due to increased afterload and left ventricular remodeling.
Purpose of the Study:
- To review the literature on the evolution of MR in patients with aortic valve disease.
- To assess the impact of concomitant MR on outcomes following aortic valve replacement (AVR).
- To identify clinical predictors of prognosis in patients with MR undergoing AVR.
Main Methods:
- Literature review and data synthesis.
- Analysis of studies reporting on MR prevalence, impact, and predictors in AVR patients.
- Examination of factors contributing to FMR in aortic valve disease.
Main Results:
- High incidence of MR (65-75%) in patients evaluated for AVR.
- FMR is linked to increased afterload and left ventricular remodeling in aortic valve disease.
- The review aims to elucidate prognostic factors for patients with concurrent MR undergoing AVR.
Conclusions:
- Understanding the interplay between aortic valve disease and MR is crucial for patient management.
- Identifying predictors of prognosis will aid in optimizing treatment strategies for patients with concomitant MR undergoing AVR.
- Further research is needed to fully elucidate the impact of MR on AVR outcomes.
Related Concept Videos
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...